Amble Erik 4
4 · Axonics Modulation Technologies, Inc. · Filed Aug 26, 2020
Insider Transaction Report
Form 4
Amble Erik
Director10% Owner
Transactions
- Award
Common Stock
2020-08-24+3,500→ 12,667 total
Holdings
- 1,520,884(indirect: By NeoMed Innovation V, L.P.)
Common Stock
Footnotes (1)
- [F1]These shares are held of record by NeoMed Innovation V, L.P. ("NeoMed"). NeoMed Innovation V Limited is the general partner of NeoMed and has voting and dispositive power over the shares held by NeoMed. Erik Amble, Ph.D., who is a member of the Issuer's board of directors, is a director of NeoMed Innovation V Limited, and may be deemed to have voting and dispositive power over the shares held by NeoMed. Mr. Amble disclaims beneficial ownership of these securities and this report shall not be deemed an admission that Mr. Amble is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his respective pecuniary interest therein.